Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-9-25
|
pubmed:abstractText |
Adriamycin has a wide spectrum of antitumor activity with dose related cardiotoxicity as a major side effect. The objective of this study was to investigate the influence of captopril, a sulphydryl containing angiotensin converting enzyme inhibitor, on the cardio- and hematotoxicity of adriamycin in normal rats. A single dose of adriamycin (15 mg/kg) caused myocardial toxicity after 24 h manifested biochemically by elevation of serum enzymes:- Aspartate transaminase (AST, EC: 2.6.1.1), lactate dehydrogenase (LDH, EC: 1.1.1.27), creatine phosphokinase (CPK, EC: 2.7.3.2) and the cardiac iso-enzymes of LDH and CPK. The hematotoxicity was characterized by severe leukopenia and anemia that appeared after 72 h of adriamycin administration. Captopril (60 mg/kg i.p.) 1 h before adriamycin injection ameliorated the biochemical toxicity induced by adriamycin. This was evidenced by a significant reduction in serum enzymes, after 24 and 48 h and a significant reduction of serum cardiac iso-enzymes after 48 h. Also restoration of the white blood cell counts as well as hemoglobin concentration occurred after 72 h of captopril administration. These results suggest that captopril may be benificial as a protective agent against cardio- and hematotoxicity induced by adriamycin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril,
http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1039-9712
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
419-27
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9678264-Animals,
pubmed-meshheading:9678264-Antibiotics, Antineoplastic,
pubmed-meshheading:9678264-Aspartate Aminotransferases,
pubmed-meshheading:9678264-Blood Cell Count,
pubmed-meshheading:9678264-Captopril,
pubmed-meshheading:9678264-Creatine Kinase,
pubmed-meshheading:9678264-Doxorubicin,
pubmed-meshheading:9678264-Erythrocyte Count,
pubmed-meshheading:9678264-Female,
pubmed-meshheading:9678264-Heart,
pubmed-meshheading:9678264-Hemoglobins,
pubmed-meshheading:9678264-Isoenzymes,
pubmed-meshheading:9678264-L-Lactate Dehydrogenase,
pubmed-meshheading:9678264-Leukocyte Count,
pubmed-meshheading:9678264-Male,
pubmed-meshheading:9678264-Rats
|
pubmed:year |
1998
|
pubmed:articleTitle |
Captopril ameliorates myocardial and hematological toxicities induced by adriamycin.
|
pubmed:affiliation |
Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
|
pubmed:publicationType |
Journal Article
|